Although the MLH1 mutation was generally known to occur in the gastrointestinal cancer susceptibility syndrome, several studies suggested that MLH1 mutation carriers have increased risk of various cancers, such as renal, pancreatic, urinary bladder, prostate, and female BC12,19–21. The gene discussed is MLH1; the disease is cancer.